[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

FI963278A - Verihiutaleen tuotantoa edistävä aine - Google Patents

Verihiutaleen tuotantoa edistävä aine Download PDF

Info

Publication number
FI963278A
FI963278A FI963278A FI963278A FI963278A FI 963278 A FI963278 A FI 963278A FI 963278 A FI963278 A FI 963278A FI 963278 A FI963278 A FI 963278A FI 963278 A FI963278 A FI 963278A
Authority
FI
Finland
Prior art keywords
polypeptide
patient
platelet counts
treating
substance
Prior art date
Application number
FI963278A
Other languages
English (en)
Swedish (sv)
Other versions
FI963278A0 (fi
FI120647B (fi
Inventor
Motoo Yamasaki
Masami Okabe
Tohiyuki Suzawa
Ken Kobayashi
Kumiko Maruyama
Original Assignee
Kyowa Hakko Kogyo Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyowa Hakko Kogyo Kk filed Critical Kyowa Hakko Kogyo Kk
Publication of FI963278A publication Critical patent/FI963278A/fi
Publication of FI963278A0 publication Critical patent/FI963278A0/fi
Application granted granted Critical
Publication of FI120647B publication Critical patent/FI120647B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/53—Colony-stimulating factor [CSF]
    • C07K14/535—Granulocyte CSF; Granulocyte-macrophage CSF
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
FI963278A 1994-02-23 1996-08-22 Verihiutaleen tuotantoa edistävä aine FI120647B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2573594 1994-02-23
JP2573594 1994-02-23
JP9500266 1995-02-23
PCT/JP1995/000266 WO1995023165A1 (fr) 1994-02-23 1995-02-23 Accelerateur de croissance des thrombocytes

Publications (3)

Publication Number Publication Date
FI963278A true FI963278A (fi) 1996-08-22
FI963278A0 FI963278A0 (fi) 1996-08-22
FI120647B FI120647B (fi) 2010-01-15

Family

ID=12174082

Family Applications (1)

Application Number Title Priority Date Filing Date
FI963278A FI120647B (fi) 1994-02-23 1996-08-22 Verihiutaleen tuotantoa edistävä aine

Country Status (18)

Country Link
US (2) US6245900B1 (fi)
EP (1) EP0744409B9 (fi)
JP (1) JP4011106B2 (fi)
KR (1) KR100403688B1 (fi)
CN (1) CN1097058C (fi)
AT (1) ATE403677T1 (fi)
AU (1) AU711535B2 (fi)
CA (1) CA2183871C (fi)
DE (1) DE69535801D1 (fi)
DK (1) DK0744409T3 (fi)
ES (1) ES2312166T3 (fi)
FI (1) FI120647B (fi)
HK (1) HK1017818A1 (fi)
HU (1) HU217872B (fi)
NO (1) NO324554B1 (fi)
NZ (1) NZ281329A (fi)
PT (1) PT744409E (fi)
WO (1) WO1995023165A1 (fi)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ334068A (en) * 1997-06-06 2000-07-28 Kyowa Hakko Kogyo Kk Polypeptides chemically modified with polyalkylene glycol derivatives
ES2264210T3 (es) 1997-09-05 2006-12-16 Kyowa Hakko Kogyo Co., Ltd. Derivados de xantina para el tratamiento de la isquemia cerebral.
US6646110B2 (en) 2000-01-10 2003-11-11 Maxygen Holdings Ltd. G-CSF polypeptides and conjugates
US6831158B2 (en) 2000-01-10 2004-12-14 Maxygen Holdings Ltd. G-CSF conjugates
US6555660B2 (en) 2000-01-10 2003-04-29 Maxygen Holdings Ltd. G-CSF conjugates
PL371781A1 (en) 2001-07-11 2005-06-27 Maxygen Holdings, Ltd. G-csf conjugates
CA2467557A1 (en) * 2001-11-19 2003-05-30 Kyowa Hakko Kogyo Co., Ltd. Agent which mobilizes multipotential stem cells from tissues to peripheral blood
US20040182795A1 (en) * 2003-03-21 2004-09-23 Randel Dorian Apparatus and method for concentration of plasma from whole blood
US20030205538A1 (en) 2002-05-03 2003-11-06 Randel Dorian Methods and apparatus for isolating platelets from blood
US7832566B2 (en) 2002-05-24 2010-11-16 Biomet Biologics, Llc Method and apparatus for separating and concentrating a component from a multi-component material including macroparticles
US7992725B2 (en) 2002-05-03 2011-08-09 Biomet Biologics, Llc Buoy suspension fractionation system
US6905612B2 (en) * 2003-03-21 2005-06-14 Hanuman Llc Plasma concentrate apparatus and method
AU2003249642A1 (en) * 2002-05-24 2003-12-12 Biomet Manufacturing Corp. Apparatus and method for separating and concentrating fluids containing multiple components
US20060278588A1 (en) 2002-05-24 2006-12-14 Woodell-May Jennifer E Apparatus and method for separating and concentrating fluids containing multiple components
US7845499B2 (en) 2002-05-24 2010-12-07 Biomet Biologics, Llc Apparatus and method for separating and concentrating fluids containing multiple components
US7611700B2 (en) * 2002-09-09 2009-11-03 Hanall Pharmaceuticals, Co., Ltd. Protease resistant modified interferon alpha polypeptides
US7763625B2 (en) * 2004-01-28 2010-07-27 Kyowa Hakko Kirin Co., Ltd. Agents for treating migraine
US7866485B2 (en) 2005-02-07 2011-01-11 Hanuman, Llc Apparatus and method for preparing platelet rich plasma and concentrates thereof
WO2006086201A2 (en) 2005-02-07 2006-08-17 Hanuman Llc Platelet rich plasma concentrate apparatus and method
WO2006086200A1 (en) * 2005-02-07 2006-08-17 Hanuman Llc Plasma concentrator device
EP2910258B1 (en) 2005-02-07 2018-08-01 Hanuman LLC Platelet rich plasma concentrate apparatus
US7694828B2 (en) 2005-04-27 2010-04-13 Biomet Manufacturing Corp. Method and apparatus for producing autologous clotting components
WO2006128460A2 (en) 2005-06-01 2006-12-07 Maxygen Holdings Ltd. Pegylated g-csf polypeptides and methods of producing same
US8567609B2 (en) 2006-05-25 2013-10-29 Biomet Biologics, Llc Apparatus and method for separating and concentrating fluids containing multiple components
WO2008127639A1 (en) 2007-04-12 2008-10-23 Biomet Biologics, Llc Buoy suspension fractionation system
US8328024B2 (en) 2007-04-12 2012-12-11 Hanuman, Llc Buoy suspension fractionation system
PT2197919E (pt) 2007-08-27 2014-07-17 Ratiopharm Gmbh Formulação líquida de conjugado de g-csf
EP2259774B1 (en) 2008-02-27 2012-12-12 Biomet Biologics, LLC Methods and compositions for delivering interleukin-1 receptor antagonist
US8337711B2 (en) 2008-02-29 2012-12-25 Biomet Biologics, Llc System and process for separating a material
US8012077B2 (en) 2008-05-23 2011-09-06 Biomet Biologics, Llc Blood separating device
US8187475B2 (en) 2009-03-06 2012-05-29 Biomet Biologics, Llc Method and apparatus for producing autologous thrombin
US8313954B2 (en) 2009-04-03 2012-11-20 Biomet Biologics, Llc All-in-one means of separating blood components
US9011800B2 (en) 2009-07-16 2015-04-21 Biomet Biologics, Llc Method and apparatus for separating biological materials
US8591391B2 (en) 2010-04-12 2013-11-26 Biomet Biologics, Llc Method and apparatus for separating a material
US9642956B2 (en) 2012-08-27 2017-05-09 Biomet Biologics, Llc Apparatus and method for separating and concentrating fluids containing multiple components
US9895418B2 (en) 2013-03-15 2018-02-20 Biomet Biologics, Llc Treatment of peripheral vascular disease using protein solutions
US9950035B2 (en) 2013-03-15 2018-04-24 Biomet Biologics, Llc Methods and non-immunogenic compositions for treating inflammatory disorders
US10208095B2 (en) 2013-03-15 2019-02-19 Biomet Manufacturing, Llc Methods for making cytokine compositions from tissues using non-centrifugal methods
US20140271589A1 (en) 2013-03-15 2014-09-18 Biomet Biologics, Llc Treatment of collagen defects using protein solutions
US10143725B2 (en) 2013-03-15 2018-12-04 Biomet Biologics, Llc Treatment of pain using protein solutions
US9550028B2 (en) 2014-05-06 2017-01-24 Biomet Biologics, LLC. Single step desiccating bead-in-syringe concentrating device
US9713810B2 (en) 2015-03-30 2017-07-25 Biomet Biologics, Llc Cell washing plunger using centrifugal force
US9757721B2 (en) 2015-05-11 2017-09-12 Biomet Biologics, Llc Cell washing plunger using centrifugal force
US10485627B2 (en) * 2016-04-07 2019-11-26 Ethicon, Inc. Containment sleeves for packages containing medical devices

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0098110B1 (en) 1982-06-24 1989-10-18 NIHON CHEMICAL RESEARCH KABUSHIKI KAISHA also known as JAPAN CHEMICAL RESEARCH CO., LTD Long-acting composition
JPS5959629A (ja) * 1982-09-27 1984-04-05 Nippon Chem Res Kk 効力持続性組成物
US4968616A (en) * 1986-05-16 1990-11-06 Masayasu Inoue Superoxide dismutase derivatives, method of producing same and medicinal use of same
JPS6360938A (ja) * 1986-09-02 1988-03-17 Meiji Milk Prod Co Ltd 修飾組織型プラスミノ−ゲン活性化因子およびその製造方法
NO176799C (no) 1986-12-23 1995-05-31 Kyowa Hakko Kogyo Kk DNA som koder for et polypeptid, rekombinant plasmid som koder for og kan uttrykke et polypeptid og fremgangsmåte for fremstilling av dette polypeptid
US5214132A (en) * 1986-12-23 1993-05-25 Kyowa Hakko Kogyo Co., Ltd. Polypeptide derivatives of human granulocyte colony stimulating factor
US5681720A (en) 1986-12-23 1997-10-28 Kyowa Hakko Co., Ltd. DNA encoding human granulocyte colony stimulating factor plasmids and host cells comprising same, and methods of expressing the encoded polypeptide
JP2532515B2 (ja) 1987-10-08 1996-09-11 水澤化学工業株式会社 血液凝集凝固剤
CA1340810C (en) 1988-03-31 1999-11-02 Motoo Yamasaki Polypeptide derivatives of human granulocyte colony stimulating factor
JPH0796558B2 (ja) * 1988-03-31 1995-10-18 協和醗酵工業株式会社 修飾ポリペプチド
JP2989002B2 (ja) * 1988-12-22 1999-12-13 キリン―アムジエン・インコーポレーテツド 化学修飾顆粒球コロニー刺激因子
US5342940A (en) 1989-05-27 1994-08-30 Sumitomo Pharmaceuticals Company, Limited Polyethylene glycol derivatives, process for preparing the same
IL96477A0 (en) 1989-12-01 1991-08-16 Amgen Inc Megakaryocyte production
JPH03215499A (ja) * 1990-01-19 1991-09-20 Green Cross Corp:The ヘモグロビン複合体
JP2975632B2 (ja) * 1990-03-30 1999-11-10 生化学工業株式会社 グリコサミノグリカン修飾プロテイン
IE912365A1 (en) * 1990-07-23 1992-01-29 Zeneca Ltd Continuous release pharmaceutical compositions
US6565841B1 (en) * 1991-03-15 2003-05-20 Amgen, Inc. Pulmonary administration of granulocyte colony stimulating factor

Also Published As

Publication number Publication date
EP0744409A1 (en) 1996-11-27
EP0744409B1 (en) 2008-08-06
HUT74807A (en) 1997-02-28
DE69535801D1 (de) 2008-09-18
JP4011106B2 (ja) 2007-11-21
CN1097058C (zh) 2002-12-25
NO963493L (no) 1996-10-23
CA2183871A1 (en) 1995-08-31
HU9602312D0 (en) 1996-10-28
NO324554B1 (no) 2007-11-19
FI963278A0 (fi) 1996-08-22
KR100403688B1 (ko) 2004-02-05
NZ281329A (en) 1997-07-27
AU1823795A (en) 1995-09-11
US20060040865A1 (en) 2006-02-23
FI120647B (fi) 2010-01-15
US6245900B1 (en) 2001-06-12
AU711535B2 (en) 1999-10-14
DK0744409T3 (da) 2008-11-10
EP0744409A4 (en) 1998-09-09
WO1995023165A1 (fr) 1995-08-31
CA2183871C (en) 2008-11-04
HK1017818A1 (en) 1999-11-26
NO963493D0 (no) 1996-08-22
HU217872B (hu) 2000-04-28
EP0744409B9 (en) 2009-08-19
PT744409E (pt) 2008-11-03
ES2312166T3 (es) 2009-02-16
US7592311B2 (en) 2009-09-22
ATE403677T1 (de) 2008-08-15
CN1150434A (zh) 1997-05-21

Similar Documents

Publication Publication Date Title
FI963278A (fi) Verihiutaleen tuotantoa edistävä aine
DE69933208D1 (de) Verwendung von zusammensetzungen mit antiseptika und/oder die wundheilung fördernden wirkstoffen für den tieferen atemwegstrakt
ATE185268T1 (de) Fortschrittliches arzneistoffabgabesystem und verfahren zur behandlung von psychiatrischen, neurologischen und anderen erkrankungen mit carbamazepin
NO169291C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktivt tetrapyrrol-amino-dicarboxylsyreaddukt
ES2162615T3 (es) Metodo para tratar o prevenir diabetes de tipo 1 mediante la administracion oral de insulina.
RU94027680A (ru) Паращитовидный гормон и ралоксифон для увеличения массы кости, фармацевтический состав и способ увеличения костной массы
WO1994008551A3 (en) Pharmaceutical compositions and methods for treating cold symptoms
EA199900499A1 (ru) Фармацевтическая композиция, включающая соединение, обладающее анти-xa активностью, и соединение антагонист агрегации тромбоцитов
BR9500436A (pt) Produtos uso de um g-csf uso de uma proteína tnf ligante processo para o tratamento e/ou prevenção do choque séptico
DK0920865T3 (da) Farmaceutiske sammensætninger indeholdende norastemizol
ATE334589T1 (de) Anti-arrhythmische zusammensetzungen und behandlungsverfahren
ATE200617T1 (de) Pharmazeutische zusammensetzungen zur transdermalen verabreichung von melatonin und/oder seine analoge
BR0212249A (pt) Composto, composição farmacêutica, método de tratamento ou profilaxia de doenças, e, uso de um composto
ATE311897T1 (de) Behandlung von multiplersklerose mit einer kombination von interferon und wachstumshormone
DE69314586D1 (de) Arzneimittelzusammensetzung enthaltend TCF-II
RU2003113210A (ru) Лечение раковых заболеваний
EA200400348A1 (ru) Цисплатиновые составы пониженной токсичности и способы их применения
KR870010871A (ko) 재조합 인체 알파 인터페론에 의한 기저세포 암종의 병소내적 치료방법
TR200201654T2 (tr) Benzamidin türevleri.
BR9812466A (pt) Uso de ifn-alfa e amantadina para o tratamento da hepatite c crÈnica
RU94000695A (ru) Средство с противоаллергическим действием
KR920700041A (ko) 치료화합물과 그의 조성 및 용도
RU2002129097A (ru) Комбинированные терапии с использованием активности, повреждающей сосуды
RU95119823A (ru) Применение диэтиламинной соли церулетида для лечения псориаза

Legal Events

Date Code Title Description
PC Transfer of assignment of patent

Owner name: KYOWA HAKKO KIRIN CO., LTD.

Free format text: KYOWA HAKKO KIRIN CO., LTD.

FG Patent granted

Ref document number: 120647

Country of ref document: FI

MM Patent lapsed